Arif B Ekici Selected Research

Borjeson-Forssman-Lehmann syndrome

11/2020

Loss of PHF6 leads to aberrant development of human neuron-like cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arif B Ekici Research Topics

Disease

50	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2009
37	Neoplasms (Cancer) 01/2021 - 05/2010
10	Ovarian Neoplasms (Ovarian Cancer) 10/2016 - 01/2011
9	Intellectual Disability (Idiocy) 01/2021 - 12/2005
8	Inflammation (Inflammations) 11/2021 - 05/2013
7	Ovarian Epithelial Carcinoma 01/2018 - 06/2011
6	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 06/2012
4	Carcinoma (Carcinomatosis) 10/2014 - 01/2011
3	Alcoholism (Alcohol Abuse) 03/2022 - 01/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 11/2010
3	Chronic Renal Insufficiency 12/2021 - 01/2017
3	Colitis 01/2019 - 01/2017
3	Fibrosis (Cirrhosis) 01/2019 - 10/2006
3	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 12/2018 - 11/2002
3	Microcephaly 12/2018 - 11/2014
3	Prostatic Neoplasms (Prostate Cancer) 02/2018 - 02/2012
3	Endometriosis 01/2018 - 11/2009
3	Kidney Diseases (Kidney Disease) 01/2018 - 09/2014
2	Gout 12/2021 - 01/2018
2	Neurodevelopmental Disorders 11/2020 - 01/2020
2	Genetic Risk Score 01/2020 - 05/2015
2	Triple Negative Breast Neoplasms 01/2019 - 06/2017
2	Arthritis (Polyarthritis) 01/2019 - 11/2010
2	Seizures (Absence Seizure) 12/2018 - 12/2014
2	Neuroblastoma 01/2018 - 09/2015
2	Turner Syndrome (Turner's Syndrome) 01/2015 - 10/2006
2	Dwarfism 01/2015 - 02/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2014 - 10/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 08/2009
2	Nausea 07/2010 - 01/2010
2	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 02/2003 - 11/2002
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 05/2022
1	Metabolic Diseases (Metabolic Disease) 05/2022
1	Vision Disorders (Hemeralopia) 05/2022
1	Neuroinflammatory Diseases 01/2022
1	Leukopenia 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Thrombotic Microangiopathies 12/2021
1	Malignant Hypertension 12/2021
1	Renovascular Hypertension (Goldblatt Syndrome) 12/2021
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 12/2021
1	Hypoxia (Hypoxemia) 11/2021

Drug/Important Bio-Agent (IBA)

28	Estrogen ReceptorsIBA 01/2021 - 07/2009
12	Proteins (Proteins, Gene)FDA Link 03/2022 - 11/2002
12	Hormones (Hormone)IBA 01/2021 - 01/2011
9	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 05/2009
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2010
8	Biological ProductsIBA 01/2019 - 10/2006
7	Transcription Factors (Transcription Factor)IBA 01/2019 - 06/2010
6	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2017
6	MicroRNAs (MicroRNA)IBA 02/2018 - 06/2011
5	Estrogens (Estrogen)FDA Link 05/2021 - 05/2009
5	Messenger RNA (mRNA)IBA 01/2020 - 11/2005
3	Complement System Proteins (Complement)IBA 01/2022 - 11/2021
3	LipidsIBA 01/2021 - 07/2014
3	EnzymesIBA 01/2020 - 10/2006
3	Biomarkers (Surrogate Marker)IBA 02/2018 - 02/2012
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2018 - 09/2014
3	ChromatinIBA 01/2018 - 07/2013
3	3' Untranslated Regions (3' UTR)IBA 01/2016 - 01/2014
3	Oral ContraceptivesIBA 10/2015 - 01/2013
2	SteroidsIBA 05/2022 - 01/2017
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 03/2022 - 12/2021
2	Uric Acid (Urate)IBA 12/2021 - 01/2018
2	Progesterone FDA LinkGeneric 01/2021 - 01/2017
2	CholesterolIBA 01/2021 - 07/2014
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2017
2	CytokinesIBA 01/2020 - 01/2017
2	human ERBB2 proteinIBA 01/2020 - 12/2011
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2020
2	SynucleinsIBA 11/2019 - 01/2016
2	InterleukinsIBA 01/2019 - 01/2017
2	A-Form DNA (A-DNA)IBA 01/2019 - 12/2018
2	PlatinumIBA 08/2018 - 02/2016
2	AnthracyclinesIBA 08/2018 - 07/2010
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2017
2	Histones (Histone)IBA 01/2018 - 12/2015
2	HLA-DQA1 antigen (HLA DQA1)IBA 10/2017 - 01/2017
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2017 - 02/2016
2	Transforming Growth Factor-beta Type II ReceptorIBA 10/2016 - 02/2015
2	LuciferasesIBA 07/2015 - 04/2013
2	Interleukin-10 (Interleukin 10)IBA 04/2014 - 10/2006
2	Nonsense Codon (Nonsense Mutation)IBA 04/2013 - 10/2012
2	Fc gamma receptor IIAIBA 11/2012 - 08/2009
2	ORALIT (ORS)IBA 06/2012 - 05/2009
2	Epidermal Growth Factor (EGF)IBA 04/2012 - 10/2011
2	OligonucleotidesIBA 02/2011 - 05/2010
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	AlbuminsIBA 12/2021
1	CreatinineIBA 12/2021
1	salicylhydroxamic acid (SHAM)IBA 12/2021
1	Complement Inactivating AgentsIBA 12/2021

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 07/2010
7	Therapeutics 01/2021 - 01/2013
2	Neoadjuvant Therapy 01/2020 - 08/2018
2	Cytoreduction Surgical Procedures 02/2016 - 12/2015
1	Fontan Procedure (Fontan Operation) 12/2021
1	Surgical Instruments (Clip) 12/2021